CoChat

The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.

Bacteroides thetaiotaomicron Ameliorates Colon Inflammation in Preclinical Models of Crohn’s Disease

Open access
Delday, Margaret, Mulder, Imke, Logan, Elizabeth T, Grant, George · 2019 · Inflammatory Bowel Diseases

Abstract

Background: Alterations in the gut microbiota are strongly associated with the development of inflammatory bowel disease (IBD), particularly with Crohn's disease, which is characterized by reduced abundance of commensal anaerobic bacteria including members of the Bacteroides genus. Our aim was to investigate the protective effects of Bacteroides thetaiotaomicron, an abundant member of this genus, in different rodent models of IBD. Methods: We assessed the effect of B. thetaiotaomicron administration on primary readouts of colitis (weight loss, histopathology, and immune parameters) in dextran sodium sulphate (DSS) and interleukin-10 knockout (IL10KO) models of IBD. Efficacy of a freeze-dried bacterial formulation and a purified recombinant protein of B. thetaiotaomicron was also investigated. Results: B. thetaiotaomicron showed protective effects in both DSS and IL10KO rodent models, as demonstrated by significant amelioration of weight loss, colon shortening, histopathological damage and immune activation. This efficacy was not exclusive to actively growing bacterial preparations but was retained by freeze-dried cells of B. thetaiotaomicron. A pirin-like protein (PLP) of B. thetaiotaomicron, identified by microarray analysis during coculture of the bacterial strain with Caco-2 cells, reduced pro-inflammatory NF-κB signalling in these intestinal epithelial cells. Recombinant PLP partially recapitulated the effect of the whole strain in a rat DSS model. Conclusions: B. thetaiotaomicron displays strong efficacy in preclinical models of IBD and protects against weight loss, histopathological changes in the colon and inflammatory markers. These data indicate that the live strain or its products may be a novel alternative to current treatment options for Crohn's disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ibd/izy281

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1. B. thetaiotaomicron is protective in C57Bl/6 mice with acute DSS-colitis. A and B, Weight change of DSS-treated mice dosed with B. thetaiotaomicron (BT) or culture media for 15 days. Mice given DSS alone displayed major weight loss, mainly over days 4–6 of DSS exposure, and this weight loss was significantly reduced in mice dosed with BT. C, Histopathology scores showed BT treatment of DSS-induced colitis significantly increased the percentage fields of view with 0 score (no pathology) and significantly decreased the percentage fields of view at score 4 (highest pathology). D, Representative images of H&E stained sections of ascending colons from indicated groups; L = lumen; GC = goblet cell; E = epithelium; I = infiltrate. E, The relative gene expression of the inflammatory mediators Il6, IL1b, Tnfα and Cxcl10 was significantly reduced with BT treatment.
FIGURE 1. B. thetaiotaomicron is protective in C57Bl/6 mice with acute DSS-colitis. A and B, Weight change of DSS-treated mice dosed with B. thetaiotaomicron (BT) or culture media for 15 days. Mice given DSS alone displayed major weight loss, mainly over days 4–6 of DSS exposure, and this weight loss was significantly reduced in mice dosed with BT. C, Histopathology scores showed BT treatment of DSS-induced colitis significantly increased the percentage fields of view with 0 score (no pathology) and significantly decreased the percentage fields of view at score 4 (highest pathology). D, Representative images of H&E stained sections of ascending colons from indicated groups; L = lumen; GC = goblet cell; E = epithelium; I = infiltrate. E, The relative gene expression of the inflammatory mediators Il6, IL1b, Tnfα and Cxcl10 was significantly reduced with BT treatment.CC BY-NC · PubMed Central
FIGURE 2. B. thetaiotaomicron is protective in an IL10KO mouse model of colitis. A, Body weight monitoring of IL10KO mice dosed 3 times weekly with BT or culture media for 13–14 weeks from weaning showed that BT treatment significantly improved weight gain, both over time and (B) assessed as total weight change at day 93. C, BT treatment of IL10KO mice resulted in an increase in the percentage fields of view with no pathology and a reduction in the fields of view scoring the highest grade of pathology. D, Macroscopic images (top panel) demonstrate the increase in ascending colon diameter from IL10KO mice compared with the WT and IL10KO/BT groups. Representative images of H&E stained ascending colon sections (middle panel) illustrate the degree of crypt hyperplasia and infiltrating inflammatory cells which occurred in these mice relative to the WT and IL10KO/BT; I = infiltrating cells; L = lumen. Representative images from WT, IL10KO, and IL10KO/BT (bottom panel) illustrate the types of images used for pathology scoring; L = lumen; E = epithelium; GC = goblet cells; C = crypt; I = infiltrate. E and F, Transcriptomics of ascending colon of BT-treated IL-10KO mice shows differential gene expression of 107 transcripts between IL10KO- and IL10KO/BT-treated mice. BT treatment particularly reduced the expression of genes related to the inflammatory response.
FIGURE 2. B. thetaiotaomicron is protective in an IL10KO mouse model of colitis. A, Body weight monitoring of IL10KO mice dosed 3 times weekly with BT or culture media for 13–14 weeks from weaning showed that BT treatment significantly improved weight gain, both over time and (B) assessed as total weight change at day 93. C, BT treatment of IL10KO mice resulted in an increase in the percentage fields of view with no pathology and a reduction in the fields of view scoring the highest grade of pathology. D, Macroscopic images (top panel) demonstrate the increase in ascending colon diameter from IL10KO mice compared with the WT and IL10KO/BT groups. Representative images of H&E stained ascending colon sections (middle panel) illustrate the degree of crypt hyperplasia and infiltrating inflammatory cells which occurred in these mice relative to the WT and IL10KO/BT; I = infiltrating cells; L = lumen. Representative images from WT, IL10KO, and IL10KO/BT (bottom panel) illustrate the types of images used for pathology scoring; L = lumen; E = epithelium; GC = goblet cells; C = crypt; I = infiltrate. E and F, Transcriptomics of ascending colon of BT-treated IL-10KO mice shows differential gene expression of 107 transcripts between IL10KO- and IL10KO/BT-treated mice. BT treatment particularly reduced the expression of genes related to the inflammatory response.CC BY-NC · PubMed Central
FIGURE 3. Lyophilized B. thetaiotaomicron maintains its protective activity in murine DSS-colitis. A, Weight change of DSS-treated mice dosed with B. thetaiotaomicron (approximately 1 × 1010 CFU /kg BW) or culture media for 8 days. Both BT and BTFD treatment reduced weight loss caused by DSS, and (B) this effect was maintained until time of termination. C, DSS treatment significantly reduced colon length; this was partially ameliorated in the BT treated group and in the BTFD group. D, DSS-induced histopathology was reduced in mice dosed with BT and BTFD. Top panel shows representative scans of H&E stained complete transverse cross sections of ascending colons. The images below show areas selected from the scans and digitally zoomed, illustrating the degree of pathology observed between groups. E, Histopathology scores show that mice treated with DSS exhibited a high degree of pathology which was significantly reduced with BT and BTFD treatment
FIGURE 3. Lyophilized B. thetaiotaomicron maintains its protective activity in murine DSS-colitis. A, Weight change of DSS-treated mice dosed with B. thetaiotaomicron (approximately 1 × 1010 CFU /kg BW) or culture media for 8 days. Both BT and BTFD treatment reduced weight loss caused by DSS, and (B) this effect was maintained until time of termination. C, DSS treatment significantly reduced colon length; this was partially ameliorated in the BT treated group and in the BTFD group. D, DSS-induced histopathology was reduced in mice dosed with BT and BTFD. Top panel shows representative scans of H&E stained complete transverse cross sections of ascending colons. The images below show areas selected from the scans and digitally zoomed, illustrating the degree of pathology observed between groups. E, Histopathology scores show that mice treated with DSS exhibited a high degree of pathology which was significantly reduced with BT and BTFD treatmentCC BY-NC · PubMed Central
FIGURE 4. B. thetaiotaomicron is partially protective against DSS-colitis in Hooded Lister rats. A, Weight gain was significantly reduced in animals given DSS. This loss of condition was not prevented in rats pretreated with BT compared with DSS alone. B, Total body weight change of DSS/BT-treated rats was not significantly different from DSS-treated rats; however, (C) the reduction in colon length was statistically improved with BT treatment, and (D) there was a statistical improvement in the percentage of fields of view with no pathology when compared with DSS.
FIGURE 4. B. thetaiotaomicron is partially protective against DSS-colitis in Hooded Lister rats. A, Weight gain was significantly reduced in animals given DSS. This loss of condition was not prevented in rats pretreated with BT compared with DSS alone. B, Total body weight change of DSS/BT-treated rats was not significantly different from DSS-treated rats; however, (C) the reduction in colon length was statistically improved with BT treatment, and (D) there was a statistical improvement in the percentage of fields of view with no pathology when compared with DSS.CC BY-NC · PubMed Central
FIGURE 5. A hypothetical protein produced by B. thetaiotaomicron is protective in rats with DSS-colitis. A, Luciferase ratios obtained for Caco-2 cells transfected with pTarget-PLP and incubated with flagellin of Salmonella enteritidis, phorbol-12–myristate-13 acetate (PMA) or IL-1 show a reduction in NF-κB-dependent responsiveness by PLP treatment. B, Body weight change across the duration of the trial showed that DSS-treated animals had the greatest growth reduction, whereas PLP treatment improved weight gain to almost similar levels as control animals. C, The total body weight change at termination of study was statistically improved in the PLP group over DSS alone. D, Colon length was significantly reduced due to intake of DSS, but this reduction in colon length was prevented when rats were also treated with PLP. E, Histopathology scores were not statistically different from DSS-treated mice, although the increase in the percentage of fields showing 0 scores showed the same trend as in the previous study.
FIGURE 5. A hypothetical protein produced by B. thetaiotaomicron is protective in rats with DSS-colitis. A, Luciferase ratios obtained for Caco-2 cells transfected with pTarget-PLP and incubated with flagellin of Salmonella enteritidis, phorbol-12–myristate-13 acetate (PMA) or IL-1 show a reduction in NF-κB-dependent responsiveness by PLP treatment. B, Body weight change across the duration of the trial showed that DSS-treated animals had the greatest growth reduction, whereas PLP treatment improved weight gain to almost similar levels as control animals. C, The total body weight change at termination of study was statistically improved in the PLP group over DSS alone. D, Colon length was significantly reduced due to intake of DSS, but this reduction in colon length was prevented when rats were also treated with PLP. E, Histopathology scores were not statistically different from DSS-treated mice, although the increase in the percentage of fields showing 0 scores showed the same trend as in the previous study.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 59 references

Cited by

See all 214

Metadata

Authors
Delday, M., Mulder, I., Logan, E. T., & Grant, G.
Affiliations
  • University of Aberdeen (GB)
  • 4D Pharma Research Ltd, Life Science Innovation Building, Aberdeen, UK
Corresponding author
Mulder, Imke
Venue
Inflammatory Bowel Diseases
Published
2018-09-12
Volume
25
Issue
1
Pages
85-96
ISSN
  • 1078-0998 (ISSN-L)
  • 1536-4844
OpenAlex
W2890463030
Cited by
193
References
59
Citations by year
2026: 20 · 2025: 33 · 2024: 32 · 2023: 31 · 2022: 30 · 2021: 22 · 2020: 18 · 2019: 6 · 2018: 1
FWCI
7.21
Type
journal article
Language
en
Open access
Locations
  • Inflammatory Bowel Diseases (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Aberdeen University Research Archive (Aberdeen University) (submittedVersion, cc-by-nc)
Funders
  • Rural and Environment Science and Analytical Services Division
  • Scottish Government
Topics
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords
Bacteroides thetaiotaomicron, Crohn's disease
MeSH terms
Bacteroides thetaiotaomicron, Animals, Colitis, Crohn Disease, Disease Models, Animal, Female, Humans, Inflammation, Mice, Inbred C57BL, Dextran Sulfate, Interleukin-10, Mice, Knockout, Caco-2 Cells, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bacteroides thetaiotaomicron Ameliorates Colon Inflammation in Preclinical Models of Crohn’s Disease. https://app.cochat.ai/papers/10.1093/ibd/izy281
The paper
Delday, M., Mulder, I., Logan, E. T., & Grant, G. (2019). Bacteroides thetaiotaomicron Ameliorates Colon Inflammation in Preclinical Models of Crohn’s Disease. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izy281

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.